Silexion Therapeutics SLXN Growth Metrics (2023-2026)

NASDAQ SLXN
$0.39 -0.01 (-1.48%)
As of: Aug 21, 2026 · 10:33 AM EDT
Growth Metrics Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Enterprise Value Growth (1y) (Quarter) 125.32%65.77%1.08%-121.22%-312.51%-368.47%97.73%60.78%35.69%
Enterprise Value Growth (3y) (Quarter) 29.80%
Enterprise Value (QoQ) (Quarter) 10.52%79.18%-131.75%158.65%-220.97%39.84%-418.28%43.66%-166.68%99.71%-8,837.04%7.63%
Interest Coverage Ratio Growth (1y) (Quarter) -309.94%79.29%107.44%-160.89%17.55%5,319.02%4,304.92%-144.16%369.78%
Interest Coverage Ratio Growth (3y) (Quarter) 123.20%
Interest Coverage Ratio (QoQ) (Quarter) -224.54%38.11%-18.41%-72.36%83.60%122.23%-4,253.10%45.53%1,137.76%-81.24%-330.21%160.19%
Return on Assets Growth (1y) (Quarter) -2.00-1.005.004.001.00-1.00
Return on Assets (QoQ) (Quarter) -1.00-4.001.003.000.001.000.00-1.00-1.00
Return on Capital Employed Growth (1y) (Quarter) 58,637.00-155995.00-246872.00-28217.00-287043.00
Return on Capital Employed (QoQ) (Quarter) 227,507.0088,820.00-270053.0012,363.0012,875.00-2058.00-51397.00-246463.00